[Cancer Therapy] Chromatin state dictates drug response

Drugs inhibiting the phosphoinositide-(3)-kinase (PI3K) signaling pathway are effective in a subset of breast cancer patients. Tumors become resistant to these drugs, however, and this – [Read More]

Source: This Week in Science - March 23, 2017 Category: Science Authors: Paula A. Kiberstis Tags: Cancer Therapy Source Type: research